BD™ AbSeq assay is one of the Top 10 innovations of 2018

BD AbSeq

The BDTM AbSeq assay has been nominated by The Scientist© magazine as one of the Top 10 Innovations of 2018

The BDTM AbSeq assay enables immunology researchers to simultaneously understand RNA and protein expression across thousands of individual cells to further their understanding of the role genes and proteins play in biological systems.  The assay brings together high-quality antibodies from the BD Pharmingen™ portfolio with oligonucleotides, allowing researchers to perform single cell protein analysis on the BD Rhapsody™ system.

In 2019 we expect to continue to expand the portfolio to leverage our vast library of human and mouse antibody clones.

The Scientist© is geared towards identifying the most innovative life science products brought to market each year. Read about the award by The Scientist© magazine here.

 

 

BD, the BD Logo, BD Pharmingen and BD Rhapsody are trademarks of Becton, Dickinson and Company. All other trademarks are the property of their respective owners © 2019 BD and its subsidiaries. All rights reserved.

For Research Use Only. Not for use in diagnostic or therapeutic procedures.